Kurt Losert 
Several notable organizations, including the Ruth Cheatham Foundation, the Northwestern Mutual Foundation, the National Children’s Cancer Society and Cancer for College are…
We are incredibly grateful to the community of researchers, clinicians, donors and patients who are supporting efforts to discover a cure for fibrolamellar. In spite of the issues caused by the Covid pandemic, highlights of 2021 include: The launch of two clinical trials for FLC The successful (virtual) gathering of over 70 scientists for the …
Congratulations to first-time marathon runner David Carles who celebrated his completion of the New York City Marathon Sunday with his brother Mark, a fibrolamellar patient. Mark, along with his critical care medical team, was brought by ambulance from the intensive care unit at New York-Presbyterian Hospital to the finish line of the race, so the …
Dr. Arfaoui, a postdoctoral researcher at Fred Hutchinson Cancer Research Center in Seattle, WA, was named the second recipient of the Brave Fellowship at Fred Hutch.
An article on fibrolamellar carcinoma (FLC) featuring Dr. Mark Yarchoan, a liver cancer specialist and assistant professor of oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, was recently published in OncLive, as part of its “Rare Cancer Series”. The October 21st article, Lessons Learned May Hold the Key for Improving Outcomes in Fibrolamellar Carcinoma, …
FCF would like to extend a special thank you to Jenny Carroll who participated in the 2021 grant review process this fall as a consumer advocate for the Congressionally
A recent article in CONQUER magazine explains the differences between genetic testing and genomic analysis, and why patients with rare cancers should have a genomic profile done. The full article, titled “Treating Rare Cancers Can Be Hard: Why Genomic Testing Is Crucial“, can be read here. CONQUER magazine features articles written by and for patients with …
On Thursday, September 30, FCF leadership moderated a Rare Cancer Day webinar sponsored by the National Organization for Rare Disorders’ (NORD) Rare Cancer Coalition. This 45-minute webinar, “Rare Cancers: Breaking Down Barriers to Diagnosis, Treatment and Research“, discusses rare cancer challenges and offers insights to assist those who are impacted. Topics covered include the challenges …
When someone is diagnosed with fibrolamellar carcinoma (FLC), they can feel isolated and alone. An extremely valuable source of support for FLC patients is finding a mentor who has already been navigating their own journey with the disease. Thanks to the efforts of many fibrolamellar community members including Tracy Oeltjenbruns and Melissa Findley, FCF is …